Real-time PCR (qPCR) And Digital PCR (dPCR) Market Analysis By Technology, By Product (Consumables & Reagents, Instruments, Software & Services), By Application, And Segment Forecasts, 2014 - 2025

Published: Aug, 2017 | Pages: 130 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global real time PCR (qPCR) and digital PCR (dPCR) market is expected to reach USD 6.3 billion by 2025, according to a new report by Grand View Research, Inc. Implementation of Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) and Real-time PCR Data Markup Language (RDML) guidelines that ensure high-quality results is estimated to provide the market with high growth opportunities

In addition, increasing number of research & forensic laboratories and CROs is a key factor responsible for market growth. Laboratories and CROs use qPCR and dPCR techniques for gene-based, protein-based, and various other research applications owing to its high accuracy and sensitivity.

Increasing preference of PCR techniques in prenatal genetic testing and its associated advantages in prenatal genetic testing such as lack of need for reference standards, low cycle times, and reproducible results are some of the drivers expected to propel growth.

Furthermore, major players are in the process of acquiring companies manufacturing diagnostic devices for the development of technologically advanced qPCR and dPCR products. For instance, Bio-Rad laboratories acquired RainDance Technologies to strengthen their position in the area of digital PCR.

Further key findings from the report suggest :

• The global qPCR and dPCR market size was estimated at USD 3.0 billion in 2016 and is expected to grow with CAGR of 8.7% from 2017 to 2025

• The quantitative segment emerged as the largest segment in 2016 due to its accuracy and high demand.

• Digital segment by technology is anticipated to witness lucrative growth owing to technological advancements such as automated processes with enhanced precision.

• The consumables and reagents segment was the largest as well as the fastest segment due to their ability to create a standardized workflow and development of novel qPCR and dPCR reagents.

• Research applications dominated the application segment owing to its wide applications in various areas of research such as agriculture, stem cells, and microbiology.

• North America dominated the market in terms of revenue share in 2016 owing to rising public and private funding and increase in grants for R&D activities in genomics.

• The Asia Pacific region is anticipated to witness lucrative growth over the next decade due to increasing investments in the field of genomics and rising awareness amongst people about the benefits of gene-based diagnosis and treatment. It is expected to grow with CAGR of 10.8% over the forecast period.

• Some of the key players including Thermo Fisher Scientific Inc.; Bio-Rad Laboratories; QIAGEN; Abbott; and Cepheid dominated the global qPCR and dPCR market in 2016.

 Table of Contents

Chapter 1 Research Methodology & Scope
                 1.1 Information Procurement
                     1.1.1 Purchased database:
                     1.1.2 GVR's internal database
                 1.2 Research Methodology
                 1.3 Geographic scope & assumptions
                 1.4 Region-wise market calculation
                     1.4.1 Region-wise market: Base estimates
                     1.4.2 Global market: CAGR calculation
                 1.5 Region-based segment share calculation
                 1.6 List of Secondary Sources
Chapter 2 Executive Summary
                 2.1 Market Snapshot
Chapter 3 Real Time PCR (qPCR) & Digital PCR (dPCR) Market Variables, Trends& Scope
                 3.1 Market segmentation& scope
                     3.1.1 Market Driver Analysis
                         3.1.1.1 Growing geriatric population base
                         3.1.1.2 Rising incidence and prevalence of chronic diseases, infectious diseases and genetic disorders.
                         3.1.1.3 Technological advancements in PCR
                         3.1.1.4 Increasing adoption of qPCR and dPCR technology.
                         3.1.1.5 Increase in the number of CROs, forensic and research laboratories.
                         3.1.1.6 Increasing demand for prenatal genetic testing procedures.
                     3.1.2 Market Restraint Analysis
                         3.1.2.1 High device cost associated with qPCR and dPCR
                         3.1.2.2 Stringent regulatory framework.
                     3.1.3 Comparative Analysis
                 3.2 Penetration & growth prospect mapping
                 3.3 Real time PCR (qPCR) and digital PCR (dPCR) - SWOT Analysis, By Factor (political & legal, economic and technological)
                 3.4 Industry Analysis - Porter's
Chapter 4 Real Time PCR (qPCR) & Digital PCR (dPCR): Technology Estimates & Trend Analysis
                 4.1 Real time PCR (qPCR) and digital PCR (dPCR) market: Technology movement analysis
                 4.2 Quantitative
                     4.2.1 Quantitative market, 2014 - 2025 (USD xx)
                 4.3 Digital
                     4.3.1 Digital market, 2014 - 2025 (USD xx)
Chapter 5 Real Time PCR (qPCR) & Digital PCR (dPCR): Product & Services & Trend Analysis
                 5.1 Real time PCR (qPCR) and digital PCR (dPCR) market: Product and Services movement analysis
                 5.2 Consumables and Reagents
                     5.2.1 Consumables & Reagents, 2014 - 2025 (USD xx)
                 5.3 Instruments
                     5.3.1 Instruments, 2014 - 2025 (USD xx)
                 5.4 Software & services
                     5.4.1 Software & services, 2014 - 2025 (USD xx)
Chapter 6 Real Time PCR (qPCR) & Digital PCR (dPCR): Application Estimates & Trend Analysis
                 6.1 Real time PCR (qPCR) and digital PCR (dPCR)market: Application movement analysis
                 6.2 Clinical
                     6.2.1 Clinical, 2014 - 2025 (USD xx)
                     6.2.2 Oncology Testing
                         6.2.2.1 Oncology testing, 2014 - 2025 (USD xx)
                     6.2.3 Blood Screening
                         6.2.3.1 Blood Screening, 2014 - 2025 (USD xx)
                     6.2.4 Pathogen Testing
                         6.2.4.1 Pathogen Testing, 2014 - 2025 (USD xx)
                     6.2.5 Others
                         6.2.5.1 Others, 2014 - 2025 (USD xx)
                 6.3 Research
                     6.3.1 Research, 2014 - 2025 (USD xx)
                 6.4 Forensics
                     6.4.1 Forensics, 2014 - 2025 (USD xx)
                 6.5 Hospitals & diagnsotic centers
                 6.6 Research Laboratories & Academic Institutes
                 6.7 Forensic Laboratories
                 6.8 Pharmaceutical & Biotechnology Companies
                 6.9 Clinical Research Organizations
Chapter 7 Real Time PCR (qPCR) & Digital PCR (dPCR): Regional Estimates & Trend Analysis, by Application
                 7.1 Real time PCR (qPCR) and digital PCR (dPCR) market share, by region, 2014 & 2025
                 7.2 North America
                 7.3 North America Real time PCR (qPCR) and Digital PCR (dPCR) Market - SWOT Analysis,
                     7.3.1 North America real time PCR (qPCR) and digital PCR (dPCR) market, 2014 - 2025 (USD Billion)
                     7.3.2 U.S
                         7.3.2.1 U.S real time PCR (qPCR) and digital PCR (dPCR) market, 2014 - 2025 (USD Billion)
                     7.3.3 Canada
                         7.3.3.1 Canada Real time PCR (qPCR) and digital PCR (dPCR) market, 2014 - 2025 (USD Billion)
                 7.4 Europe
                 7.5 Europe Real time PCR (qPCR) and Digital PCR (dPCR) Market - SWOT Analysis,
                     7.5.1 Europe Real time PCR (qPCR) and digital PCR (dPCR) market, 2014 - 2025 (USD Billion)
                     7.5.2 UK
                         7.5.2.1 UK Real time PCR (qPCR) and digital PCR (dPCR) market, 2014 - 2025 (USD Billion)
                     7.5.3 Germany
                         7.5.3.1 Germany Real time PCR (qPCR) and digital PCR (dPCR) market, 2014 - 2025 (USD Billion)
                 7.6 Asia Pacific
                 7.7 Asia Pacific Real time PCR (qPCR) and Digital PCR (dPCR) Market - SWOT Analysis,
                     7.7.1 Asia Pacific Real time PCR (qPCR) and digital PCR (dPCR) market, 2014 - 2025 (USD Billion)
                     7.7.2 Japan
                         7.7.2.1 Japan Real time PCR (qPCR) and digital PCR (dPCR) market, 2014 - 2025 (USD Billion)
                     7.7.3 China
                         7.7.3.1 China Real time PCR (qPCR) and digital PCR (dPCR) market, 2014 - 2025 (USD Billion)
                     7.7.4 India
                         7.7.4.1 India Real time PCR (qPCR) and digital PCR (dPCR) market, 2014 - 2025 (USD Billion)
                 7.8 Latin America
                 7.9 Latin America Real time PCR (qPCR) and Digital PCR (dPCR) Market - SWOT Analysis,
                     7.9.1 Latin America Real time PCR (qPCR) and digital PCR (dPCR) market, 2014 - 2025 (USD Billion)
                     7.9.2 Brazil
                         7.9.2.1 Brazil Real time PCR (qPCR) and digital PCR (dPCR) market, 2014 - 2025 (USD Billion)
                     7.9.3 Mexico
                         7.9.3.1 Mexico Real time PCR (qPCR) and digital PCR (dPCR) market, 2014 - 2025 (USD Billion)
                 7.10 MEA
                 7.11 MEA Real time PCR (qPCR) and Digital PCR (dPCR) Market - SWOT Analysis,
                     7.11.1 MEA Real time PCR (qPCR) and digital PCR (dPCR) market, 2014 - 2025 (USD Billion)
                     7.11.2 South Africa
                         7.11.2.1 South Africa Real time PCR (qPCR) and digital PCR (dPCR) market, 2014 - 2025 (USD Billion)
Chapter 8 Competitive Landscape
                 8.1 Strategy Framework
                 8.2 Market Participation Categorization
                 8.3 Company Profiles
                     8.3.1 Affymetrix, Inc.
                         8.3.1.1 Company Overview
                         8.3.1.2 Financial performance
                     8.3.2 Thermo Fisher Scientific, Inc.
                         8.3.2.1 Company Overview
                         8.3.2.2 Financial performance
                         8.3.2.1 Product benchmarking
                         8.3.2.2 Strategic initiatives
                     8.3.3 Bio-Rad Laboratories Inc.
                         8.3.3.1 Company Overview
                         8.3.3.2 Financial performance
                         8.3.3.3 Product benchmarking
                         8.3.3.4 Strategic initiatives
                     8.3.4 Qiagen N.V.
                         8.3.4.1 Company Overview
                         8.3.4.2 Financial performance
                         8.3.4.1 Product benchmarking
                         8.3.4.2 Strategic initiatives
                     8.3.5 Abbott Laboratories, Inc.
                         8.3.5.1 Company Overview
                         8.3.5.2 Financial performance
                         8.3.5.3 Product benchmarking
                         8.3.5.4 Strategic initiatives
                     8.3.6 Cepheid
                         8.3.6.1 Company Overview
                         8.3.6.2 Financial performance
                         8.3.6.3 Product benchmarking
                         8.3.6.4 Strategic initiatives
                     8.3.7 Agilent Technologies, Inc.
                         8.3.7.1 Company Overview
                         8.3.7.2 Financial performance
                         8.3.7.3 Product benchmarking
                         8.3.7.4 Strategic initiatives
                     8.3.8 GE Healthcare
                         8.3.8.1 Company Overview
                         8.3.8.2 Financial performance
                         8.3.8.3 Product benchmarking
                         8.3.8.4 Strategic initiatives
                     8.3.9 biomérieux S.A.
                         8.3.9.1 Company Overview
                         8.3.9.2 Financial performance8.3.9.3 Product benchmarking
                         8.3.9.4 Strategic initiatives
                     8.3.10 F. Hoffman-La Roche
                         8.3.10.1 Company Overview
                         8.3.10.2 Financial performance
                         8.3.10.3 Product benchmarking
                         8.3.10.4 Strategic initiatives
                     8.3.11 Fluidigm Corporation
                         8.3.11.1 Company Overview
                         8.3.11.2 Financial performance
                         8.3.11.3 Product benchmarking
                         8.3.11.4 Strategic initiatives

List of Tables

TABLE 1 Country share estimation
TABLE 2 Prevalence of diseases
TABLE 3 North America real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 4 North America real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 5 North America real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 6 North America clinical application by type market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 7 North America real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 8 U.S. real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 9 U.S. real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 10 U.S. real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 11 U.S. clinical application by type market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 12 U.S. real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 13 Canada real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 14 Canada real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 15 Canada real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 16 Canada clinical application by type market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 17 Canada real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 18 Europe real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 19 Europe real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 20 Europe real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 21 Europe clinical application by type market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 22 Europe real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 23 UK real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 24 UK real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 25 UK real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 26 UK clinical application by type market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 27 UK real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 28 Germany real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 29 Germany real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 30 Germany real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 31 Germany clinical application by type market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 32 Germany real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 33 Asia Pacific real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 34 Asia Pacific real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 35 Asia Pacific real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 36 Asia Pacific clinical application by type market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 37 Asia Pacific real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 38 Japan real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 39 Japan real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 40 Japan real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 41 Japan clinical application by type market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 42 Japan real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 43 China real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 44 China real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 45 China real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 46 China clinical application by type market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 47 China real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 48 India real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 49 India real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 50 India real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 51 India clinical application by type market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 52 India real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 53 Latin America real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 54 Latin America real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 55 Latin America real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 56 Latin America clinical application by type market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 57 Latin America real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 58 Brazil real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 59 Brazil real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 60 Brazil real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 61 Brazil clinical application by type market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 62 Brazil real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 63 Mexico real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 64 Mexico real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 65 Mexico real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 66 Mexico clinical application by type market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 67 Mexico real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 68 MEA real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 69 MEA real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 70 MEA real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 71 MEA clinical application by type market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 72 MEA real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 73 South Africa real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 74 South Africa real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 75 South Africa real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 76 South Africa clinical application by type market estimates and forecasts, application, 2014 - 2025 (USD Million)
TABLE 77 South Africa real-time PCR (qPCR) and digital PCR (dPCR) market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)